LFCO Human Leukocyte Antigen DQB Site Typing Reagent - Taiwan Registration 90a4105e5e2eeebff452f319b52622e9
Access comprehensive regulatory information for LFCO Human Leukocyte Antigen DQB Site Typing Reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 90a4105e5e2eeebff452f319b52622e9 and manufactured by GEN-PROBE TRANSPLANT DIAGNOSTICS, INC.. The authorized representative in Taiwan is METEK LAB INC..
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including GEN-PROBE TRANSPLANT DIAGNOSTICS, INC., and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
Polymerase chain reaction (PCR) was used to detect the presence or absence of human leukocyte antigen DQB (HLA-DQB) with Luminex fluorescence analyzer.
B Hematology, pathology, and genetics
B.0001 Human leukocyte antigen typing test system
import
Dates and Status
Jul 24, 2012
Jul 24, 2017
Jul 21, 2016
Cancellation Information
Logged out
่ช่ซ่จป้ท